-
10008612-100azido-FTY720 is a highly photoreactive analog of FTY720 that can be used to identify receptor binding sites for this ligand.
-
10008612-5azido-FTY720 is a highly photoreactive analog of FTY720 that can be used to identify receptor binding sites for this ligand.
-
10008612-500azido-FTY720 is a highly photoreactive analog of FTY720 that can be used to identify receptor binding sites for this ligand.
-
15004-100A macrolide antibiotic with high stability at acidic pH, long half-life, and favorable effectiveness against a range of organisms.
-
15004-25A macrolide antibiotic with high stability at acidic pH, long half-life, and favorable effectiveness against a range of organisms.
-
15004-250A macrolide antibiotic with high stability at acidic pH, long half-life, and favorable effectiveness against a range of organisms.
-
15004-50A macrolide antibiotic with high stability at acidic pH, long half-life, and favorable effectiveness against a range of organisms.
-
18424-1A semi-synthetic with broad spectrum antibacterial properties used as part of antibiotic cocktails known as PANTA (with polymyxin B, amphotericin B, nalidixic acid, and trimethoprim) and PANTAV (PANTA with vancomycin).
-
18424-250A semi-synthetic with broad spectrum antibacterial properties used as part of antibiotic cocktails known as PANTA (with polymyxin B, amphotericin B, nalidixic acid, and trimethoprim) and PANTAV (PANTA with vancomycin).
-
18424-500A semi-synthetic with broad spectrum antibacterial properties used as part of antibiotic cocktails known as PANTA (with polymyxin B, amphotericin B, nalidixic acid, and trimethoprim) and PANTAV (PANTA with vancomycin).
-
18045-10A small molecule that at 1-25 µM improves ER protein-folding ability, stimulates the expression of multiple chaperone proteins, and induces phosphorylation of eIF2&alpha to reduce protein synthesis exerts antidiabetic activity in both ob/ob
-
18045-25A small molecule that at 1-25 µM improves ER protein-folding ability, stimulates the expression of multiple chaperone proteins, and induces phosphorylation of eIF2&alpha to reduce protein synthesis exerts antidiabetic activity in both ob/ob